%PDF-1.4
%
194 0 obj
<>>>
endobj
195 0 obj
<>/Font<>>>/Fields[]>>
endobj
191 0 obj
<>
endobj
179 0 obj
<>stream
Adobe PDF Library 15.0
False
2018-04-07T03:52:39+08:00
2018-04-11T16:14:50-07:00
2018-04-11T16:14:50-07:00
Adobe InDesign CC 2017 (Windows)
uuid:8e883082-1dd2-11b2-0a00-c900e8b5a7ff
xmp.did:f4fd3488-9b3f-9d45-a5a3-8a4b2d55f952
xmp.id:a16e783a-39f3-f04c-aad2-e8a145ff5235
proof:pdf
xmp.iid:d4af7031-1731-8f44-824c-07e540d887a0
xmp.did:887d751a-9a88-4b4f-bdf7-66728a478f75
xmp.did:f4fd3488-9b3f-9d45-a5a3-8a4b2d55f952
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2018-04-07T03:52:39+08:00
application/pdf
Science Journals — AAAS
endstream
endobj
173 0 obj
<>
endobj
52 0 obj
<>
endobj
24 0 obj
<>
endobj
110 0 obj
<>
endobj
101 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/XObject<>>>/Rotate 0/Thumb 102 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
114 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/Thumb 120 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
115 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Thumb 128 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
116 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 139 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
117 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 141 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
118 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 150 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
119 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 152 0 R/TrimBox[0 0 594 756]/Type/Page>>
endobj
213 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
235 0 obj
[240 0 R 241 0 R 242 0 R 243 0 R 244 0 R 245 0 R 246 0 R 247 0 R 248 0 R 249 0 R]
endobj
236 0 obj
<>stream
q
304.25 0 0 21.75 84 662.25 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 84 622 Tm
(Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 84 584.99991 Tm
(Singer, Robert A. Coleman, Amit Verma and Ulrich Steidl)Tj
0 1 TD
(Guerlavais, D. Allen Annis, Boris Bartholdy, Britta Will, Jesus D. Anamp\
a, Ioannis Mantzaris, Manuel Aivado, Robert H.)Tj
0 1.00001 TD
(Swathi-Rao Narayanagari, Justin C. Wheat, Tihomira I. Todorova, Kelly Mi\
tchell, Charles Kenworthy, Vincent )Tj
0 1 TD
(Luis A. Carvajal, Daniela Ben Neriah, Adrien Senecal, Lumie Benard, Vict\
or Thiruthuvanathan, Tatyana Yatsenko,)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 84 538.99997 Tm
(DOI: 10.1126/scitranslmed.aao3003)Tj
8.05798 1 Td
(, eaao3003.)Tj
/T1_0 1 Tf
-1.112 0 Td
(10)Tj
/T1_2 1 Tf
-6.94598 0 Td
(Sci Transl Med )Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 104 442.99976 Tm
(models, along with preliminary testing in a patient with leukemia.)Tj
T*
(demonstrated the effectiveness of this approach in human acute myeloid l\
eukemia using in vitro and in vivo)Tj
0 1.00001 TD
(endogenous inhibitors, for situations where the tumor suppressor is inac\
tive but not completely lost. The authors )Tj
5.83499 1 Td
(. applied yet another tactic to restore p53 activity by using a stapled \
peptide to inactivate both of its)Tj
/T1_2 1 Tf
-1.89 0 Td
(et al)Tj
/T1_1 1 Tf
-3.94499 0 Td
(Carvajal )Tj
T*
(reactivate p53 by a variety of approaches, none have successfully advanc\
ed beyond clinical trials thus far. Now, )Tj
0 1 TD
(variety of cancer types, often through up-regulation of its endogenous s\
uppressors. Despite numerous attempts to)Tj
T*
(activity is often lost in cancer cells. One of the best known tumor supp\
ressors is p53, which is inactivated in a )Tj
3.125 1.00001 Td
(As suggested by their name, tumor suppressor genes prevent tumorigenesis\
, and their expression or)Tj
/T1_0 1 Tf
-3.125 1 Td
(A new staple of leukemia treatment?)Tj
ET
BT
/T1_0 1 Tf
6 0 0 6 91 397 Tm
(ARTICLE TOOLS)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 395 Tm
(http://stm.sciencemag.org/content/10/436/eaao3003)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 354.99997 Tm
(MATERIALS)Tj
0 1.00001 TD
(SUPPLEMENTARY )Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 359 Tm
(http://stm.sciencemag.org/content/suppl/2018/04/09/10.436.eaao3003.DC1)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 312.99997 Tm
(CONTENT)Tj
T*
(RELATED )Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 292.99991 Tm
(http://stm.sciencemag.org/content/scitransmed/9/413/eaao1214.full)Tj
0 1 TD
(http://stm.sciencemag.org/content/scitransmed/10/429/eaam7729.full)Tj
0 1.00001 TD
(http://stm.sciencemag.org/content/scitransmed/10/431/eaam8460.full)Tj
0 1 TD
(http://stm.sciencemag.org/content/scitransmed/4/148/148ra117.full)Tj
ET
BT
0 g
/T1_0 1 Tf
6 0 0 6 91 277 Tm
(REFERENCES)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 266.99997 Tm
(http://stm.sciencemag.org/content/10/436/eaao3003#BIBL)Tj
0 g
T*
(This article cites 90 articles, 31 of which you can access for free)Tj
ET
BT
/T1_0 1 Tf
6 0 0 6 91 241 Tm
(PERMISSIONS)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 199 239 Tm
(http://www.sciencemag.org/help/reprints-and-permissions)Tj
ET
BT
/T1_1 1 Tf
8 0 0 8 205.38391 128 Tm
(Terms of Service)Tj
0 g
-15.17299 0 Td
(Use of this article is subject to the )Tj
ET
84 114 m
510 114 l
0 0 m
S
BT
ET
BT
/T1_1 1 Tf
8 0 0 8 211.59985 77.99991 Tm
( is a registered trademark of AAAS.)Tj
/T1_2 1 Tf
-13.83798 0 Td
(Science Translational Medicine)Tj
/T1_1 1 Tf
-2.112 0 Td
(title )Tj
T*
(licensee American Association for the Advancement of Science. No claim t\
o original U.S. Government Works. The)Tj
0 1.00001 TD
(Science, 1200 New York Avenue NW, Washington, DC 20005. 2017 \251 The Au\
thors, some rights reserved; exclusive )Tj
14.11598 1 Td
(\(ISSN 1946-6242\) is published by the American Association for the Adva\
ncement of)Tj
/T1_2 1 Tf
-14.11598 0 Td
(Science Translational Medicine )Tj
ET
BT
/T1_1 1 Tf
0 -8 8 0 578 346.22015 Tm
( by guest on April 11, 2018)Tj
0 0 1 rg
-11.72697 0 Td
(http://stm.sciencemag.org/)Tj
0 g
-8.11399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
239 0 obj
<>/Filter/FlateDecode/Height 87/Length 66928/Name/X/Subtype/Image/Type/XObject/Width 1217>>stream
HT{gf
(Kbc`$H1)1cZ=&Vi1IGi4ԪTL@9DARPy.(1硫3̽f XU]ksM&D3㘀L}E